These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 16374884)

  • 1. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
    Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
    J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
    Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
    Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
    Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
    Blamek S; Larysz D; Ficek K; Sokół M; Miszczyk L; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():183-6. PubMed ID: 19812945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
    Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
    Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
    Porto L; Kieslich M; Franz K; Lehrbecher T; Pilatus U; Hattingen E
    Brain Tumor Pathol; 2010 Oct; 27(2):65-70. PubMed ID: 21046307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
    Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
    Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
    Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
    J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.